Noninferiority of Novel Subcutaneous Infliximab (CT-P13) to Intravenous Infliximab (CT-P13) in Patients with Active Crohn's Disease and Ulcerative Colitis: Week 30 Results from a Multicentre, Randomised Controlled Pivotal Trial

Stefan Schreiber  1     Jaroslaw Leszczyszyn  2     Robert Dudkowiak  2     Adi Lahat  3     Beata Gawdis-Wojnarska  4     Aldis Pukitis  5     Marek Horynski     Katalin Farkas     Jaroslaw KierkuĊ›     Maciej Kowalski     Shomron Ben-Horin     Byong Duk Ye     Sang Joon Lee     Sung Hyun Kim     Mi Rim Kim     Han Na Kim     Walter Reinisch    
1 University Hospital Schleswig-Holstein,Kiel,Germany
2 Melita Medical,Wroclaw,Poland
3 Chaim Sheba Medical Center and Sackler School of Medicine Tel Aviv University,Ramat Gan,Israel
4 Twoja Przychodnia - Szczecińskie Centrum Medyczne,Szczecin,Poland
5 Pauls Stradins Clinical University Hospital,Riga,

Session
Late breaking abstracts: IBD Highlights

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing